These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34067093)

  • 1. Impact of the Uncoupling Protein 1 on Cardiovascular Risk in Patients with Rheumatoid Arthritis.
    Lyngfelt LI; Erlandsson MC; Nadali M; Hedjazifar S; Pullerits R; Andersson KM; Brembeck P; Silfverswärd ST; Smith U; Bokarewa MI
    Cells; 2021 May; 10(5):. PubMed ID: 34067093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives.
    Promelle V; Goeb V; Gueudry J
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34068884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL.
    Chatzidionysiou K; Circiumaru A; Rethi B; Joshua V; Engstrom M; Hensvold A; Af Klint E; Catrina A
    RMD Open; 2021 Jun; 7(2):. PubMed ID: 34112702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies.
    Genovese MC; Durez P; Fleischmann R; Tanaka Y; Furst D; Yamanaka H; Korneva E; Vasyutin I; Takeuchi T
    Eur J Rheumatol; 2021 Jul; 8(3):120-129. PubMed ID: 34101570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Adverse Events Among Home- vs Facility-Administered Biologic Infusions, 2007-2017.
    Baker MC; Weng Y; Fairchild R; Ahuja N; Rohatgi N
    JAMA Netw Open; 2021 Jun; 4(6):e2110268. PubMed ID: 34081140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates.
    Jouve T; Laheurte C; Noble J; Weinhard J; Daligault M; Renaudin A; Naciri Bennani H; Masson D; Gravelin E; Bugnazet M; Bardy B; Malvezzi P; Saas P; Rostaing L
    Am J Transplant; 2022 Jan; 22(1):71-84. PubMed ID: 34080291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients.
    Milligan C; Atassi N; Babu S; Barohn RJ; Caress JB; Cudkowicz ME; Evora A; Hawkins GA; Wosiski-Kuhn M; Macklin EA; Shefner JM; Simmons Z; Bowser RP; Ladha SS
    Muscle Nerve; 2021 Sep; 64(3):309-320. PubMed ID: 34075589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
    Morris G; Bortolasci CC; Puri BK; Marx W; O'Neil A; Athan E; Walder K; Berk M; Olive L; Carvalho AF; Maes M
    Cytokine; 2021 Aug; 144():155593. PubMed ID: 34074585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years.
    Campochiaro C; Allanore Y
    Arthritis Res Ther; 2021 Jun; 23(1):155. PubMed ID: 34074331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old and New Challenges in Uveitis Associated with Behçet's Disease.
    Gueudry J; Leclercq M; Saadoun D; Bodaghi B
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34073249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of first, second, and third-line bDMARDs and tsDMARD with drug survival among seropositive rheumatoid arthritis patients: Cohort study in A real world setting.
    Choi S; Ghang B; Jeong S; Choi D; Lee JS; Park SM; Lee EY
    Semin Arthritis Rheum; 2021 Aug; 51(4):685-691. PubMed ID: 34139521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis.
    Asai S; Takahashi N; Kobayakawa T; Kaneko A; Watanabe T; Kato T; Nishiume T; Ishikawa H; Yoshioka Y; Kanayama Y; Watanabe T; Hirano Y; Hanabayashi M; Yabe Y; Yokota Y; Suzuki M; Terabe K; Ishiguro N; Imagama S; Kojima T
    Clin Rheumatol; 2021 Aug; 40(8):3143-3151. PubMed ID: 34136969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression.
    Rodriguez-García SC; Montes N; Ivorra-Cortes J; Triguero-Martinez A; Rodriguez-Rodriguez L; Castrejón I; Carmona L; González-Álvaro I
    Front Med (Lausanne); 2021; 8():669688. PubMed ID: 34136506
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission.
    Hammer HB; Jensen Hansen IM; Järvinen P; Leirisalo-Repo M; Ziegelasch M; Agular B; Terslev L
    Rheumatol Adv Pract; 2021; 5(2):rkab030. PubMed ID: 34131623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis.
    Seitz L; Christ L; Lötscher F; Scholz G; Sarbu AC; Bütikofer L; Kollert F; Schmidt WA; Reichenbach S; Villiger PM
    Rheumatology (Oxford); 2021 Nov; 60(11):5052-5059. PubMed ID: 34117737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant cell arteritis: what is new in the preclinical and early clinical development pipeline?
    Harkins P; Conway R
    Expert Opin Investig Drugs; 2022 Sep; 31(9):921-932. PubMed ID: 34106030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 Directed Therapy in Transplantation.
    Miller CL; Madsen JC
    Curr Transplant Rep; 2021; 8(3):191-204. PubMed ID: 34099967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series.
    Brown RA; Barbar-Smiley F; Yildirim-Toruner C; Ardura MI; Ardoin SP; Akoghlanian S
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):84. PubMed ID: 34098976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction.
    George MJ; Jasmin NH; Cummings VT; Richard-Loendt A; Launchbury F; Woollard K; Turner-Stokes T; Garcia Diaz AI; Lythgoe M; Stuckey DJ; Hingorani AD; Gilroy DW
    JACC Basic Transl Sci; 2021 May; 6(5):431-443. PubMed ID: 34095633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal case of TAFRO syndrome with unilateral adrenal hemorrhage in early-stage disease.
    Okamoto T; Ochi S; Motokawa Y; Azumi H; Kobayashi S; Nakamura F; Nakatani T; Yagi H
    J Clin Exp Hematop; 2021; 61(2):109-113. PubMed ID: 34092711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.